A 7-year-old boy from a village in Uttar Pradesh with active trachoma (TF stage) undergoes screening in a trachoma elimination programme. The ophthalmologist performs slit-lamp examination and observes follicles on the upper tarsal conjunctiva. What is the most appropriate investigation to differentiate active trachoma from follicular conjunctivitis due to other causes?

Explanation

## Differentiating Active Trachoma from Other Follicular Conjunctivitis **Key Point:** PCR targeting Chlamydia trachomatis 16S rRNA gene is the most specific and sensitive investigation to confirm active trachoma and differentiate it from non-chlamydial follicular conjunctivitis. ### Clinical Challenge: Follicular Conjunctivitis Differential Follicular conjunctivitis can be caused by: - **Chlamydia trachomatis** (trachoma) — requires specific antibiotic therapy - **Viral agents** (adenovirus, herpes simplex) — self-limiting or antiviral therapy - **Allergic reactions** — topical antihistamines/corticosteroids - **Bacterial toxins** — supportive care ### Why PCR is the Best Differentiator | Aspect | PCR (16S rRNA) | CIC + Giemsa | Tear Osmolarity | AS-OCT | |---|---|---|---|---| | **Detects C. trachomatis specifically** | Yes, highly specific | Indirect, low sensitivity | No | No | | **Differentiates from viral causes** | Yes | No | No | No | | **Sensitivity in active TF** | >95% | 50–60% | N/A | N/A | | **Practical in field settings** | Yes, rapid tests available | Requires microscopy | Requires equipment | Requires equipment | | **Cost-effective** | Moderate | Low | High | High | **High-Yield:** PCR is the WHO-recommended confirmatory test for active trachoma in elimination programmes because it: 1. Directly detects Chlamydia DNA 2. Has >95% sensitivity and >99% specificity 3. Guides appropriate antibiotic therapy (azithromycin) 4. Helps monitor treatment response **Mnemonic: PCR-TF** — **P**olymerase **C**hain **R**eaction for **T**rachomatous **F**ollicles (active stage) **Clinical Pearl:** In endemic areas, rapid point-of-care PCR tests are increasingly used for screening and confirmation, enabling rapid case identification and treatment initiation. [cite:Park 26e Ch 8; WHO Simplified Trachoma Grading System]